AU5414400A - 1,4-diazacycloheptane derivatives as neuroprotective agents - Google Patents

1,4-diazacycloheptane derivatives as neuroprotective agents

Info

Publication number
AU5414400A
AU5414400A AU54144/00A AU5414400A AU5414400A AU 5414400 A AU5414400 A AU 5414400A AU 54144/00 A AU54144/00 A AU 54144/00A AU 5414400 A AU5414400 A AU 5414400A AU 5414400 A AU5414400 A AU 5414400A
Authority
AU
Australia
Prior art keywords
neuroprotective agents
diazacycloheptane derivatives
diazacycloheptane
derivatives
neuroprotective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54144/00A
Other languages
English (en)
Inventor
Margaret Joyce Schooler
Thomas Richard Simpson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca UK Ltd
Original Assignee
AstraZeneca UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca UK Ltd filed Critical AstraZeneca UK Ltd
Publication of AU5414400A publication Critical patent/AU5414400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU54144/00A 1999-06-17 2000-06-14 1,4-diazacycloheptane derivatives as neuroprotective agents Abandoned AU5414400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9914026 1999-06-17
GBGB9914026.1A GB9914026D0 (en) 1999-06-17 1999-06-17 Chemical compounds
PCT/GB2000/002308 WO2000078736A1 (en) 1999-06-17 2000-06-14 1,4-diazacycloheptane derivatives as neuroprotective agents

Publications (1)

Publication Number Publication Date
AU5414400A true AU5414400A (en) 2001-01-09

Family

ID=10855476

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54144/00A Abandoned AU5414400A (en) 1999-06-17 2000-06-14 1,4-diazacycloheptane derivatives as neuroprotective agents

Country Status (5)

Country Link
EP (1) EP1192141A1 (ja)
JP (1) JP2003502411A (ja)
AU (1) AU5414400A (ja)
GB (1) GB9914026D0 (ja)
WO (1) WO2000078736A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113908174A (zh) * 2021-10-29 2022-01-11 北京四环制药有限公司 一种高效安全的脑蛋白水解物制备方法及其应用
CN115112800A (zh) * 2022-07-01 2022-09-27 河南润弘制药股份有限公司 一种改进的用于盐酸法舒地尔注射液中高哌嗪的检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1335591C (en) * 1988-05-23 1995-05-16 James Arthur Nixon Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes
PL203140B1 (pl) * 1997-10-27 2009-08-31 Neurosearch As Pochodna homopiperazyny, kompozycja farmaceutyczna zawierająca te pochodne i zastosowanie tej pochodnej
GB9726736D0 (en) * 1997-12-18 1998-02-18 Zeneca Ltd Chemical compounds
JP2002533447A (ja) * 1998-12-24 2002-10-08 アストラゼネカ・アクチエボラーグ 神経疾患の治療に有用な１，４−ジアザシクロヘプタン誘導体

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113908174A (zh) * 2021-10-29 2022-01-11 北京四环制药有限公司 一种高效安全的脑蛋白水解物制备方法及其应用
CN115112800A (zh) * 2022-07-01 2022-09-27 河南润弘制药股份有限公司 一种改进的用于盐酸法舒地尔注射液中高哌嗪的检测方法
CN115112800B (zh) * 2022-07-01 2023-07-07 河南润弘制药股份有限公司 一种改进的用于盐酸法舒地尔注射液中高哌嗪的检测方法

Also Published As

Publication number Publication date
EP1192141A1 (en) 2002-04-03
GB9914026D0 (en) 1999-08-18
WO2000078736A1 (en) 2000-12-28
JP2003502411A (ja) 2003-01-21

Similar Documents

Publication Publication Date Title
AU4006800A (en) 1,2-dithiolane derivatives
AU4137400A (en) Heterocyclic derivatives useful as anticancer agents
AU6314900A (en) Biarylurea derivatives
AU6714700A (en) Cyclopropylindole derivatives
PL351611A1 (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
AUPP873799A0 (en) Pyridine compounds
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AU6281100A (en) Novel diketopiperazines
AU2623399A (en) 3-hydroxy-4-aryl-5-pyrazoline derivatives as herbicides
AU6014900A (en) Staurosporin derivatives
AU3819200A (en) 2,4-diamino-pyrimidine derivatives
AU7319800A (en) 4-oxybenzopyran derivative
AU2541000A (en) Beta-phenylalanine derivatives as integrin antagonists
AU5429000A (en) Novel bicyclonucleoside derivatives
AU3670000A (en) Novel thiazolobenzimidazole derivatives
AU7952800A (en) 2-alkoxybenzene derivatives
AU7453900A (en) 4-oxybenzopyran derivative
AU5568400A (en) Novel dihydropyrimidine derivatives
AU7963300A (en) Novel bipyridyl derivatives
AU2199201A (en) Anthracene derivatives as anti-cancer agents
AU5887400A (en) Derivative compounds
AU6050500A (en) Benzothiophene derivatives
AU1558300A (en) 1-cycloalkylpyrazoyl-benzoyl derivatives
AU6262300A (en) Indolinylamide derivatives
AU7448300A (en) Novel pyridine derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase